CLIMB BIO, INC. Increase (Decrease) in Accounts Payable
CLIMB BIO, INC. (CLYM) reported Increase (Decrease) in Accounts Payable of -$1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- CLIMB BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $200.00K, a 115.05% increase year-over-year.
- CLIMB BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.41M, a 2056.94% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.79M, a 332.85% increase year-over-year.
- CLIMB BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$393.00K.
- CLIMB BIO, INC. increase (decrease) in accounts payable for fiscal 2025 was $1.56M.
- CLIMB BIO, INC. increase (decrease) in accounts payable for fiscal 2024 was -$963.00K.
- CLIMB BIO, INC. increase (decrease) in accounts payable for fiscal 2023 was -$686.00K.
- CLIMB BIO, INC. increase (decrease) in accounts payable for fiscal 2022 was -$653.00K, a 305.35% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.21M 10-Q · filed 2026-08-06 | $583.00K derived: sum of 3 quarters · filed 2026-08-06 | $190.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$1.41M 10-Q · filed 2026-05-07 | $383.00K derived: sum of 2 quarters · filed 2026-05-07 | -$10.00K derived: sum of 3 quarters · filed 2026-05-07 | $83.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.40M derived: sum of 2 quarters · filed 2026-03-05 | $1.49M derived: sum of 3 quarters · filed 2026-08-06 | $1.56M 10-K · filed 2026-03-05 | ||
| 2025-09-30 | -$393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$300.00K derived: sum of 2 quarters · filed 2026-08-06 | -$228.00K 10-Q · filed 2025-11-06 | $186.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $165.00K 10-Q · filed 2026-08-06 | $579.00K derived: sum of 3 quarters · filed 2026-08-06 | $362.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $72.00K 10-Q · filed 2026-05-07 | $486.00K derived: sum of 2 quarters · filed 2026-05-07 | $269.00K derived: sum of 3 quarters · filed 2026-05-07 | -$911.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $197.00K derived: sum of 2 quarters · filed 2026-03-05 | -$983.00K derived: sum of 3 quarters · filed 2026-03-05 | -$963.00K 10-K · filed 2026-03-05 | ||
| 2024-09-30 | -$217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.40M derived: sum of 2 quarters · filed 2025-11-06 | -$1.38M 10-Q · filed 2025-11-06 | -$2.05M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.16M 10-Q · filed 2025-08-12 | -$1.83M derived: sum of 3 quarters · filed 2025-08-12 | -$1.97M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-14 | -$652.00K derived: sum of 2 quarters · filed 2025-05-14 | -$794.00K derived: sum of 3 quarters · filed 2025-05-14 | -$780.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$814.00K derived: sum of 2 quarters · filed 2025-03-25 | -$800.00K derived: sum of 3 quarters · filed 2025-03-25 | -$686.00K 10-K · filed 2025-03-25 | ||
| 2023-09-30 | -$142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$128.00K derived: sum of 2 quarters · filed 2024-11-12 | -$14.00K 10-Q · filed 2024-11-12 | -$758.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $128.00K 10-Q · filed 2024-08-14 | -$616.00K derived: sum of 3 quarters · filed 2024-08-14 | -$203.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $114.00K 10-Q · filed 2024-05-15 | -$630.00K derived: sum of 2 quarters · filed 2024-05-15 | -$217.00K derived: sum of 3 quarters · filed 2024-05-15 | $17.00K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$744.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$331.00K derived: sum of 2 quarters · filed 2024-03-28 | -$97.00K derived: sum of 3 quarters · filed 2024-03-28 | -$653.00K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $647.00K derived: sum of 2 quarters · filed 2023-11-14 | $91.00K 10-Q · filed 2023-11-14 | -$878.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$322.00K 10-Q · filed 2023-08-10 | -$343.00K 10-Q · filed 2022-08-15 | -$1.29M derived: sum of 3 quarters · filed 2023-08-10 | -$875.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$556.00K 10-Q · filed 2023-05-11 | -$1.52M derived: sum of 2 quarters · filed 2023-05-11 | -$1.11M derived: sum of 3 quarters · filed 2023-05-11 | -$1.16M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$969.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$553.00K derived: sum of 2 quarters · filed 2023-03-06 | -$599.00K derived: sum of 3 quarters · filed 2023-03-06 | $318.00K 10-K · filed 2023-03-06 | ||
| 2021-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $370.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.29M 10-Q · filed 2022-11-14 | $1.49M 10-Q · filed 2021-11-08 | $1.04M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $871.00K 10-Q · filed 2022-08-15 | $622.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.08M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $917.00K 10-Q · filed 2022-05-16 | $668.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.13M derived: sum of 3 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $214.00K derived: sum of 2 quarters · filed 2022-03-07 | -$167.00K 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $82.00K 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | -$381.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |